Our events

"SLAM family receptors as novel targets for anti-cancer immunotherapy" Dr. André Veillette, Director, Molecular Oncology Research Unit, Montreal Clinical Research Institute and Executive Director, Marathon of Hope Cancer Centres Network, Terry Fox Research Institute

"Tissue protective effects of oncogenic p53 mutation in a mouse model" Yinon Ben-Neriah, MD-PhD, Professor of immunology and cancer research at the Hebrew University of Jerusalem

"Mapping non-canonical neutrophils lineages in cancer" Dr. Daniela Cerezo-Wallis, Associate Research Scientist, Yale School of Medicine, USA

"Identifying and targeting MYC protein-protein interactions" Linda Z. Penn, Ph.D., Canadian Research Chair in Molecular Oncology (Tier 1), UHN Director, Office of Research Trainees (ORT), Senior Scientist, Princess Margaret Cancer Centre, University Health Network,Professor, Department of Medical Biophysics, University of Toronto

"Decoding Aneuploidies - using CRISPR technologies in mice to unravel novel cancer driver genes and vulnerabilities in recurrent CAN" Dr. Daniel Schramek, Senior Investigator and the Deputy Director at the Lunenfeld-Tanenbaum Research Institute/Mount Sinai Hospital in Toronto, and a Professor at the Department of Molecular Genetics, Temerty Faculty of Medicine

"The tiring task of studying NK cell exhaustion" Dr. Dr. Michele Ardolino, PhD, Professor, Dept. of Biochemistry, Microbiology & Immunology, University of Ottawa, Senior Scientist and Associate Program Director, Cancer Therapeutics Program, Ottawa Hospital Research Institute